CVSA — Covista Inc. stock price, charts and financials

NYSE·Consumer Defensive·Education & Training Services·USA

Latest market price

127.49

+2.64+2.11%

Overview Short InterestFilings

CVSAQT58Covista Inc.·NYSE

Overview Short InterestFilings

127.49+2.11%

Loading chart...

Signal & projected range

Gap down — mean-reversionHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

LOPE+3.81%$150.88 GHC+0.79%$1213.07 LRN-0.24%$80.10 LAUR-1.77%$37.63 TAL-3.36%$12.08 UTI+5.11%$41.32 MH+4.84%$11.49 PRDO+2.39%$32.57

Snapshot

Index	-	P/E	17.78	EPS (ttm)	7.02	Insider Own	2.03%	Shs Outstand	34.03M	Perf Week	7.78%

Market Cap	4.25B	Forward P/E	12.59	EPS next Y	9.91	Insider Trans	-3.07%	Shs Float	33.20M	Perf Month	-2.64%

Enterprise Value	4.84B	PEG	1.14	EPS next Q	-	Inst Own	-	Short Float	5.07%	Perf Quarter	8.36%

Income	232.41M	P/S	2.22	EPS this Y	29.37%	Inst Trans	-	Short Ratio	5.18	Perf Half Y	-

Sales	1.91B	P/B	3.14	EPS next Y	11.54%	ROA	8.55%	Short Interest	1.68M	Perf YTD	25.87%

Book/sh	-	P/C	10.54	EPS next 5Y	11.86%	ROE	16.62%	52W High	138.83 -8.17%	Perf Year	-

Cash/sh	-	P/FCF	12.63	EPS past 3/5Y	- 10.17%	ROIC	12.78%	52W Low	96.21 32.51%	Perf 3Y	-

Dividend Est.	-	EV/EBITDA	11.23	Sales past 3/5Y	8.96% 11.19%	Gross Margin	57.28%	Volatility	5.11% 4.57%	Perf 5Y	-

Dividend TTM	-	EV/Sales	2.53	EPS Y/Y TTM	100.88%	Oper. Margin	19.15%	ATR (14)	5.73	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	0.70	Sales Y/Y TTM	20.44%	Profit Margin	12.26%	RSI (14)	51.71	Recom	2.00

Dividend Gr. 3/5Y	-	Current Ratio	0.70	EPS Q/Q	0.00%	SMA20	0.71%	Beta	-0.40	Target Price	140.00

Payout	0.00%	Debt/Eq	0.54	Sales Q/Q	4.51%	SMA50	0.77%	Rel Volume	1.03	Prev Close	124.85

Employees	10,371	LT Debt/Eq	0.52	Earnings	Aug 06	SMA200	5.88%	Avg Volume	337.39K	Price	127.49

IPO Date	Feb 25, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	14.95% 2.75%	Net Debt/EBITDA	1.36	Volume	347,032	Change	2.11%

Analyst Ratings

Date	Action	Analyst	Rating	Target
May-11-26	Reiterated	Truist Securities	Buy	$140

Latest News

Jul-28-26

Jul-28-2608:00AM

Covista Names Emily C. Chiu and Leslie Storms to its Board of Directorsbusinesswire.com

Jul-24-26

Jul-24-2610:33AM

Stride: Record Guidance, Recent Turnaround, And Trading At A Discount To PeersSeekingAlpha

Jul-22-26

Jul-22-2606:40PM

Covista Inc (CVSA) Shares Fall 3.7% -- GF Value Says Still Overvaluedgurufocus.com

Jul-20-26

Jul-20-2609:00AM

Covista Earns Five National Honors Recognizing its Workplace Culture, Career Growth Opportunities and Commitment to Responsible Businessbusinesswire.com

Jul-13-26

Jul-13-2609:00AM

Covista and the Covista Foundation Commit $10 Million and 50,000 Volunteer Hours to Build and Sustain the Healthcare Workforcegurufocus.com

Jul-07-26

Jul-07-2608:37PM

Is Covista Inc (CVSA) Overvalued After 4.6% Rally? GF Value Says Overvaluedgurufocus.com

09:00AM

Covista Announces Fourth Quarter and Fiscal Year 2026 Conference Callgurufocus.com

Jul-01-26

Jul-01-2610:41AM

Covista (CVSA) is a Top-Ranked Value Stock: Should You Buy?zacks.com

Jun-29-26

Jun-29-2605:00AM

Covista and Advocate Health Launch Strategic Nursing Collaboration to Strengthen Workforce Readiness and Expand Patient Accessbusinesswire.com

Company

Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J. Keller and Ronald L. Taylor established the company in 1973, and its corporate headquarters are situated in Chicago, Illinois.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 6/30/2025	FY 2024 6/30/2024	FY 2023 6/30/2023	FY 2022 6/30/2022	FY 2021 6/30/2021	FY 2020 6/30/2020	FY 2019 6/30/2019	FY 2018 6/30/2018
Total Revenue	1,909	1,788	1,585	1,451	1,382	907	1,052	1,014	1,236
Cost of Goods Sold Incl. D&A	816	771	699	677	730	447	484	469	625
Gross Profit	1,094	1,017	886	774	652	460	568	545	611
Selling, General and Administrative Excl. Other	724	671	614	576	566	292	280	359	328
Research and Development	0	0	0	0	0	0	0	0	0
Other Operating Expense	4	4	55	-28	-70	12	122	3	52
Operating Income	365	342	217	226	156	157	166	183	230
Interest Expense	47	52	64	63	99	43	9	20	15
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	6	9	11	-51	-108	-30	80	-23	-17
Net Income Before Taxes	326	299	164	112	-51	83	237	140	199
Income Taxes	76	66	26	10	-16	13	-6	33	84
Consolidated Net Income	234	233	137	97	-162	77	202	129	34
Net Income From Continuing Operations	249	233	138	102	-36	70	244	107	114
Net Income	234	233	137	97	-162	77	202	129	34
EPS (Recurring)	7.02	6.27	3.49	2.27	-3.36	1.50	3.77	2.20	0.55
EPS (Basic, Before Extraordinaries)	7.02	6.27	3.49	2.27	-3.36	1.50	3.77	2.20	0.55
EPS (Diluted)	6.87	6.07	3.42	2.23	-3.36	1.49	3.74	2.17	1.10
EBITDA	431	427	347	326	264	211	266	223	283
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	18.56	20.96	19.94	15.40	—	23.92	8.33	20.76	43.73
Price To Sales Ratio	2.27	2.63	1.72	1.06	1.25	2.00	1.60	2.62	2.37
Gross Margin	57.31	56.88	55.90	53.34	47.18	50.72	53.99	53.75	49.43
Operating Margin	19.12	19.13	13.69	15.58	11.29	17.31	15.78	18.05	18.61
Net Margin	12.26	13.03	8.64	6.69	-11.72	8.49	19.20	12.72	2.75
Shares Outstanding	34	37	40	45	48	51	54	59	61
Market Capitalization	4,335	4,708	2,728	1,545	1,727	1,818	1,682	2,658	2,934
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Beard, Stephen W.	Chairman & CEO	Jul 13 '26	Sale	132.75	5,291	702,401	418,742	Jul 15
BECK DOUGLAS G.	SVP, GC, Corp. Sec & ISS	Jul 08 '26	Sale	135.34	2,439	330,092	33,070	Jul 09
Phelan Robert J.	Chief Financial Officer	Jul 08 '26	Sale	135.39	2,414	326,822	50,492	Jul 09
BECK DOUGLAS G.	SVP, GC, Corp. Sec & ISS	Jul 07 '26	Sale	135.40	2,650	358,818	35,509	Jul 09
Phelan Robert J.	Chief Financial Officer	Jul 07 '26	Sale	135.41	2,900	392,677	52,906	Jul 09
Beard, Stephen W.	Chairman & CEO	Jun 11 '26	Sale	130.78	2,529	330,755	424,033	Jun 12
Beard, Stephen W.	Chairman & CEO	Jun 10 '26	Sale	130.14	2,762	359,443	426,562	Jun 12
Phelan Robert J.	Chief Financial Officer	May 08 '26	Sale	126.21	10,000	1,262,064	55,806	May 12
BECK DOUGLAS G.	SVP, GC, Corp. Sec & ISS	May 08 '26	Sale	127.03	9,615	1,221,381	38,159	May 12
Cox Karen Sue	President, Chamberlain Univ.	May 08 '26	Sale	124.50	2,000	249,000	31,596	May 12
Beard, Stephen W.	Chairman & CEO	May 08 '26	Sale	131.25	15,874	2,083,509	429,324	May 12
MALAFRONTE MICHAEL W	director, other: Lead Independent Director	Mar 11 '26	Buy	100.94	8,890	897,341	25,395	Mar 12
MALAFRONTE MICHAEL W	director, other: Lead Independent Director	Mar 10 '26	Buy	100.86	27,146	2,738,073	113,205	Mar 12
MALAFRONTE MICHAEL W	director, other: Lead Independent Director	Mar 03 '26	Buy	97.97	1,200	117,564	1,200	Mar 05

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.